Viral Screening

Automated chemiluminescent immunoassay an alternative to NAT

Published in Blood Weekly, June 27th, 2002

by Sonia Nichols, senior medical writer - Nucleic acid amplification testing (NAT) can detect products of viral infection in the blood much earlier than serological testing can but at a higher cost in terms of time and expense. Now, a team at Abbott Laboratories has announced the development of an automated assay that could be a feasible alternative to hepatitis C virus (HCV) RNA testing.

Immediately after an individual becomes infected with HCV, there exists a period of time, reportedly as long as 70 days, where circulating antibody levels are so low that they cannot be detected with standard serological testing. With the advent of more sensitive techniques that can...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry